Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaul Sar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Harefuah|October 31, 2022
[OCULAR MANIFESTATIONS IN BEHÇET DISEASE]Shaul Sar, Oren Tomkins-Netzer
Harefuah|May 12, 2024
[CLINICAL MANIFESTATIONS OF AUTOIMMUNE DISEASES]Hana Shyriaiev, Shaul Sar, Oren Tomkins-Netzer
Harefuah|March 26, 2025
[MEDICATIONS AND VACCINE-ASSOCIATED UVEITIS]Shaul Sar, Oren Yovel, Oren Tomkins-Netzer
Ophthalmology|June 1, 2022
Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis: A Population-Based StudyOren Tomkins-Netzer, Shaul Sar, Ofra Barnett-Griness, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 22, 2012
Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degenerationNurit Mathalone, Anat Arodi-Golan, Shaul Sar, et al.
Clinical Rheumatology|December 11, 2023
The risk factors for uveitis among psoriatic arthritis patients: a population-based cohort studyNizar Hijazi, Tal Gazitt, Amir Haddad, et al.
The British Journal of Ophthalmology|July 11, 2025
Adalimumab biosimilars have similar efficacy to originator adalimumab when treating non-infectious uveitisOren Tomkins-Netzer, Rachael L Niederer, Radgonde Amer, et al.
Acta Ophthalmologica|February 8, 2023
Retinal vascular occlusions in ocular Behçet disease - a comparative analysisMichael Ostrovsky, Dan Ramon, Salam Iriqat, et al.
Biomedicines|February 25, 2023
Ocular Behçet Disease-Clinical Manifestations, Treatments and Outcomes According to Age at Disease OnsetMichael Ostrovsky, Amir Rosenblatt, Salam Iriqat, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Harefuah|October 31, 2022
[OCULAR MANIFESTATIONS IN BEHÇET DISEASE]Shaul Sar, Oren Tomkins-Netzer
Harefuah|May 12, 2024
[CLINICAL MANIFESTATIONS OF AUTOIMMUNE DISEASES]Hana Shyriaiev, Shaul Sar, Oren Tomkins-Netzer
Harefuah|March 26, 2025
[MEDICATIONS AND VACCINE-ASSOCIATED UVEITIS]Shaul Sar, Oren Yovel, Oren Tomkins-Netzer
Ophthalmology|June 1, 2022
Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis: A Population-Based StudyOren Tomkins-Netzer, Shaul Sar, Ofra Barnett-Griness, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 22, 2012
Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degenerationNurit Mathalone, Anat Arodi-Golan, Shaul Sar, et al.
Clinical Rheumatology|December 11, 2023
The risk factors for uveitis among psoriatic arthritis patients: a population-based cohort studyNizar Hijazi, Tal Gazitt, Amir Haddad, et al.
The British Journal of Ophthalmology|July 11, 2025
Adalimumab biosimilars have similar efficacy to originator adalimumab when treating non-infectious uveitisOren Tomkins-Netzer, Rachael L Niederer, Radgonde Amer, et al.
Acta Ophthalmologica|February 8, 2023
Retinal vascular occlusions in ocular Behçet disease - a comparative analysisMichael Ostrovsky, Dan Ramon, Salam Iriqat, et al.
Biomedicines|February 25, 2023
Ocular Behçet Disease-Clinical Manifestations, Treatments and Outcomes According to Age at Disease OnsetMichael Ostrovsky, Amir Rosenblatt, Salam Iriqat, et al.
Pageof 1